Egg Immunoglobulins TRIZ Cases

Periodic antigen exposure with egg testing sustains high IgY yolk levels, yielding eggs with 20% more antibodies for oral pathogen defense.

Chicken egg yolk IgY targeting the Mpox A29 fusion protein enables rapid passive protection with high specificity and lower host immune interaction.

Avian IgY antibodies in a bovine colostrum matrix help survive digestion and provide broad-spectrum oral protection against animal diarrhea pathogens.

Pseudogene-driven gene conversion diversifies long cysteine-rich CDR3 regions in transgenic chicken antibodies, improving stable antigen binding.

Avian IgY antibodies improve host cell protein detection sensitivity and specificity, enabling 2-6 ng/mL limits for safer therapeutic protein purity.

Targeted egg-derived antibodies against Enterococcus faecalis and cytolysin help reduce liver injury and support ALD and GVHD treatment.

Sodium alginate, carboxymethyl cellulose, and piperine help deliver IgY antibodies to shrimp against WSSV.

Specific egg-derived antibodies target Enterococcus faecalis and its cytolysin toxin to reduce liver injury in alcoholic liver disease.

Transgenic chickens produce long CDR3 antibodies stabilized by cysteine disulfide bridges for stronger antigen recognition.

A protective material such as colostrum helps oral IgY antibodies resist gastric acid and digestive enzymes, preserving passive immunity.

Immunized egg-laying avians produce purified anti-CVA16 IgY that binds capsid epitopes and neutralizes CVA16 and EV-A71.

Antibodies bind the beta-lactamase omega loop, preventing antibiotic degradation and supporting treatment of resistant bacterial infections.

Centrifugation, PEG precipitation, and ultrafiltration purify egg-yolk IgY above 98% without costly chromatographic steps.

Affinity chromatography with recombinant CWP1 and alpha-giardin purifies specific antibodies to resolve false negatives from intermittent parasite excretion.

An antibody fragment penetrates virus-infected cells and binds to influenza A virus RNA.

Antibody-containing milk and egg products deliver localized treatment to non-infectious conditions, reducing systemic side effects.

Oral antibodies inhibit secretory phospholipase A2-IB enzyme activity in the gastrointestinal tract.

Polyclonal IgY antibodies bind microbial antigens to inhibit pathogen proliferation while preserving beneficial skin microbiota.

Multi-strain emulsified vaccine with QS-21 adjuvant overcomes RNA virus mutation limits to provide broad-spectrum protection.

Avian antibodies from immunized birds bind and neutralize bacterial toxins in animal subjects.

Proteomic analysis identifies specific antigens that trigger protective IgY antibodies, offering a sustainable control strategy against poultry red mites.

Covalent antigen attachment to surfactants prevents burst release and stabilizes hydrophilic antigens during storage in industrial emulsions.

A method to produce antibodies against the SARS-CoV-2 spike protein using immunization with specific peptides that stabilize proteolytic cleavage sites.

Avian antibodies from immunized hens bind methanogens in the rumen, reducing methane emissions and improving feed conversion efficiency.

Ovopach hyperimmune eggs deliver patient-specific IgY antibodies to neutralize antibiotic-resistant pathogens in psoriasis wounds.

MEDI4736 binds B7-H1 to block PD-1 and CD80 receptors, resolving immune evasion in resistant tumors.

Oral avian IgY antibodies cross the digestive barrier into neonatal serum, preventing allergic reactions from repeated mammalian antisera injections.

Yolk antibodies from immunized fowl eggs target hepatitis virus antigens to lower viral titers and liver enzyme levels in infected subjects.

A purification process for immunoglobulin Y using precipitation and liquid-liquid extraction.

CRISPR knock-in poultry eggs express exogenous genes under ovalbumin promoters, resolving instability from random viral integration.

I-spga immunogen combines pathogen strains with SPGA and QS-21 to produce hyperimmune eggs, preserving antigenic structures lost in formalin methods.

Targeting the CHI3L1/CD44 axis with monoclonal antibodies extends the treatment window for acute liver failure by preventing late-stage platelet accumulation.

Hyperimmunized eggs secrete high-titer antibodies that block viral entry by inhibiting spike protein binding to the ACE2 receptor.

ELISA test kit detects equine albumin and hemoglobin in feces to identify digestive tract bleeding.

Antibodies neutralize endotoxins to resolve the trade-off between treatment effectiveness and side effects in chronic pain management.